Healthcare provider profile · identity verified

Christopher K Catton, MD

Internal Medicine · YAKIMA, WA · NPI 1588685515

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	700	197
Losartan Potassium	Losartan Potassium	586	164
Levothyroxine Sodium	Levothyroxine Sodium	514	141
Lisinopril	Lisinopril	453	130
Amlodipine Besylate	Amlodipine Besylate	409	125
Omeprazole	Omeprazole	372	101
Metoprolol Succinate	Metoprolol Succinate	266	79
Simvastatin	Simvastatin	231	63
Rosuvastatin Calcium	Rosuvastatin Calcium	224	67
Hydrochlorothiazide	Hydrochlorothiazide	204	60
Pantoprazole Sodium	Pantoprazole Sodium	186	50
Potassium Chloride	Potassium Chloride	173	59
Metformin Hcl	Metformin Hcl	163	50
Citalopram Hbr	Citalopram Hydrobromide	151	40
Pravastatin Sodium	Pravastatin Sodium	148	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	147	47
Sertraline Hcl	Sertraline Hcl	143	36
Furosemide	Furosemide	140	42
Metformin Hcl Er	Metformin Hcl	138	43
Gabapentin	Gabapentin	133	36
Carvedilol	Carvedilol	132	40
Lovastatin	Lovastatin	129	36
Eliquis	Apixaban	123	29
Metoprolol Tartrate	Metoprolol Tartrate	123	33
Escitalopram Oxalate	Escitalopram Oxalate	112	27
Warfarin Sodium	Warfarin Sodium	106	36
Allopurinol	Allopurinol	105	32
Tamsulosin Hcl	Tamsulosin Hcl	93	29
Duloxetine Hcl	Duloxetine Hcl	87	19
Montelukast Sodium	Montelukast Sodium	82	18
Trazodone Hcl	Trazodone Hcl	82	26
Alendronate Sodium	Alendronate Sodium	71	26
Bupropion Xl	Bupropion Hcl	69	19
Atenolol	Atenolol	64	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	16
Albuterol Sulfate Hfa	Albuterol Sulfate	58	25
Oxycodone Hcl	Oxycodone Hcl	57	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	57	16
Spironolactone	Spironolactone	57	17
Tramadol Hcl	Tramadol Hcl	54	19
Alprazolam	Alprazolam	52	22
Clopidogrel	Clopidogrel Bisulfate	52	16
Propranolol Hcl	Propranolol Hcl	52	13
Clonazepam	Clonazepam	49	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	13
Fluticasone Propionate	Fluticasone Propionate	49	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	21
Lorazepam	Lorazepam	45	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	11
Meloxicam	Meloxicam	43	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	suppressed
Xarelto	Rivaroxaban	41	14
Prednisone	Prednisone	38	23
Chlorthalidone	Chlorthalidone	37	12
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	26
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Famotidine	Famotidine	30	12
Ondansetron Odt	Ondansetron	29	15
Verapamil Er	Verapamil Hcl	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Glipizide	Glipizide	28	12
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Glimepiride	Glimepiride	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	17
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	21
Ozempic	Semaglutide	21	suppressed
Celecoxib	Celecoxib	19	suppressed
Estradiol	Estradiol	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Cephalexin	Cephalexin	18	15
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Norgestimate-Ethinyl Estradiol	Norgestimate-Ethinyl Estradiol	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	13
Diazepam	Diazepam	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Nitroglycerin	Nitroglycerin	17	13
Ramipril	Ramipril	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Baclofen	Baclofen	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Finasteride	Finasteride	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nystatin	Nystatin	15	12
Creon	Lipase/Protease/Amylase	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Primidone	Primidone	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Levofloxacin	Levofloxacin	12	11
Nifedipine Er	Nifedipine	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Trimethoprim	Trimethoprim	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error